Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - MEDICIS PHARMACEUTICAL CORP | p16939e10vk.htm |
| EX-12 - EX-12 - MEDICIS PHARMACEUTICAL CORP | p16939exv12.htm |
| EX-21.1 - EX-21.1 - MEDICIS PHARMACEUTICAL CORP | p16939exv21w1.htm |
| EX-31.2 - EX-31.2 - MEDICIS PHARMACEUTICAL CORP | p16939exv31w2.htm |
| EX-31.1 - EX-31.1 - MEDICIS PHARMACEUTICAL CORP | p16939exv31w1.htm |
| EX-10.74 - EX-10.74 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w74.htm |
| EX-10.70 - EX-10.70 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w70.htm |
| EX-10.71 - EX-10.71 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w71.htm |
| EX-10.75 - EX-10.75 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w75.htm |
| EX-10.72 - EX-10.72 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w72.htm |
| EX-10.73 - EX-10.73 - MEDICIS PHARMACEUTICAL CORP | p16939exv10w73.htm |
| EX-32.2 - EX-32.2 - MEDICIS PHARMACEUTICAL CORP | p16939exv32w2.htm |
| EX-32.1 - EX-32.1 - MEDICIS PHARMACEUTICAL CORP | p16939exv32w1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 Nos. 33-45573,
33-88590, 33-311419, 33-333647, 333-81647, 333-101467, 333-126785, 333-135675 and 333-147705), and
in the Registration Statements (Form S-3 No. 333-97207 and Form S-4 No. 333-107089) of Medicis
Pharmaceutical Corporation of our reports dated February 24, 2009, with respect to the consolidated
financial statements and schedule of Medicis Pharmaceutical Corporation and the effectiveness of
internal control over financial reporting of Medicis Pharmaceutical Corporation, included in its
Annual Report (Form 10-K) for the year ended December 31, 2009.
/s/ Ernst & Young LLP
Phoenix, Arizona
March 1, 2010
March 1, 2010